VG Life Sciences Inc. (VGLS)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | - | - | 1.32 Million | 1.86 Million |
| Total Current Assets | - | - | - | - | 246.26 Thousand | 789.38 Thousand |
| Cash And Short Term Investments | - | - | - | - | 33.99 Thousand | 713.89 Thousand |
| Cash and Cash Equivalents | - | - | - | - | 33.99 Thousand | 713.89 Thousand |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | 212.27 Thousand | 75.49 |
| Total Non-Current Assets | - | - | - | - | 1.07 Million | 1.07 Million |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | 1.07 Million | 1.07 Million |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | 1.07 Million | 1.07 Million |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | -0.00 |
| Total Liabilities | 4.61 Million | 5 Million | 8.8 Million | 7.72 Million | 5.82 Million | 6.33 Million |
| Total Current Liabilities | 4.61 Million | 5 Million | 8.8 Million | 7.72 Million | 5.82 Million | 6.33 Million |
| Account Payables | - | - | - | - | 710.34 Thousand | 405 Thousand |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 2.18 Million | 2.6 Million | 4.65 Million | 3.87 Million | 3.86 Million | 3.2 Million |
| Deferred Revenue | - | - | - | - | 534.36 Thousand | 504.36 Thousand |
| Other Current Liabilities | 2.43 Million | 2.39 Million | 4.15 Million | 3.84 Million | 723.2 Thousand | 2.21 Million |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | -4.61 Million | -5 Million | -8.8 Million | -7.72 Million | -4.5 Million | -4.46 Million |
| Stock Holders Equity | -4.61 Million | -5.46 Million | -9.26 Million | -8.21 Million | -5.17 Million | -5.16 Million |
| Common Stock | 1.74 Million | 278.64 Thousand | 47.82 Thousand | 12.99 Thousand | 4622.00 | 1746.00 |
| Retained Earnings | -116.92 Million | -115.86 Million | -114.62 Million | -113.16 Million | -105.96 Million | -99.77 Million |
| Accumulated other comprehensive income | -1.74 Million | -278.64 Thousand | -47.82 Thousand | -12.99 Thousand | - | - |
| Common Stock Equity | -4.61 Million | -5.46 Million | -9.26 Million | -8.21 Million | -5.17 Million | -5.16 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | 2.18 Million | 2.6 Million | 4.65 Million | 3.87 Million | 3.86 Million | 3.2 Million |
| Net Debt | 2.18 Million | 2.6 Million | 4.65 Million | 3.87 Million | 3.82 Million | 2.49 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | - | - | - | - |
| Total Current Assets | - | - | - | - | - | - |
| Cash And Short Term Investments | - | - | - | - | - | - |
| Cash and Cash Equivalents | - | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - | - |
| Net Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - | - |
| Total Non-Current Assets | - | - | - | - | - | - |
| Net PPE | - | - | - | - | - | - |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | - | - | - | - | - | - |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 4.55 Million | 4.63 Million | 4.59 Million | 4.61 Million | 4.61 Million | 4.44 Million |
| Total Current Liabilities | 4.55 Million | 4.63 Million | 4.59 Million | 4.61 Million | 4.61 Million | 4.44 Million |
| Account Payables | - | - | - | - | - | - |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 2.11 Million | 2.19 Million | 2.15 Million | 2.18 Million | 2.18 Million | 2.04 Million |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 2.44 Million | 2.44 Million | 2.44 Million | 2.43 Million | 2.43 Million | 2.4 Million |
| Total Non Current Liabilities | - | - | - | - | - | - |
| Long-Term Debt | - | - | - | - | - | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | - | - | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | -4.55 Million | -4.63 Million | -4.59 Million | -4.61 Million | -4.61 Million | -4.44 Million |
| Stock Holders Equity | -4.55 Million | -4.63 Million | -4.59 Million | -4.61 Million | -4.61 Million | -4.44 Million |
| Common Stock | 1.91 Million | 1.74 Million | 1.91 Million | 1.74 Million | 1.74 Million | 1.91 Million |
| Retained Earnings | -116.95 Million | -116.95 Million | -116.94 Million | -116.92 Million | -116.92 Million | -116.87 Million |
| Accumulated other comprehensive income | -1.91 Million | -1.74 Million | -1.91 Million | -1.74 Million | -1.74 Million | -1.91 Million |
| Common Stock Equity | -4.55 Million | -4.63 Million | -4.59 Million | -4.61 Million | -4.61 Million | -4.44 Million |
| Capital Lease Obligation | - | - | - | - | - | - |
| Total Investments | - | - | - | - | - | - |
| Total Debt | 2.11 Million | 2.19 Million | 2.15 Million | 2.18 Million | 2.18 Million | 2.04 Million |
| Net Debt | 2.11 Million | 2.19 Million | 2.15 Million | 2.18 Million | 2.18 Million | 2.04 Million |
4886
TELDF
ACGI
0LQQ
DRCT
ULTJ